Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy 2004; 24: 856–870., , .
Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005; 46: 31–41., , , , , .
Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001; 57: 1774–1779., , , .
Zonisamide in pediatric epilepsy: review of the Japanese literature. Journal of Child Neurology 2002; 17: 87–96., .
Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center. Journal of Child Neurology 2005; 20: 212–219., , .
Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients. Epilepsy Research 1998; 29: 109–114., .
Practical prescribing and long-term efficacy and safety of zonisamide. Epilepsy Research 2006; 68S; S17-S24..
Zonisamide and associated oligohydrosis and hyperthermia. Epilepsy Research 2004; 62: 27–34., , , , .
Clinical pharmacology and therapeutic drug monitoring of zonisamide. Therapeutic Drug Monitoring 1998; 29: 593–597..
Anti-epileptic drug interactions. A clinical guide. Clarius Press: Guildford, UK; 2005..
Long-term response to zonisamide in patients with West syndrome. Neurology 2002; 58: 1556–1559., , , , , , , , , , , , , , , , .
Zonisamide monotherapy in newly diagnosed infantile spasms. Epilepsia 1997; 38: 1035–1038., , , , , , , , .